Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Sees Significant Increase in Short Interest

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) was the recipient of a significant increase in short interest in April. As of April 30th, there was short interest totaling 770 shares, an increase of 116.3% from the April 15th total of 356 shares. Based on an average daily trading volume, of 5,950 shares, the days-to-cover ratio is currently 0.1 days. Currently, 0.0% of the shares of the stock are sold short.

Fidelity Disruptive Medicine ETF Trading Down 2.6%

FMED stock opened at $24.06 on Friday. The firm has a 50 day moving average of $24.86 and a 200-day moving average of $26.27. The firm has a market capitalization of $55.34 million, a P/E ratio of 41.33 and a beta of 0.84. Fidelity Disruptive Medicine ETF has a 12 month low of $22.80 and a 12 month high of $29.07.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. Wealth Enhancement Advisory Services LLC grew its position in shares of Fidelity Disruptive Medicine ETF by 4.6% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 714,991 shares of the company’s stock valued at $19,712,000 after purchasing an additional 31,629 shares in the last quarter. Jane Street Group LLC raised its position in shares of Fidelity Disruptive Medicine ETF by 95.4% in the fourth quarter. Jane Street Group LLC now owns 91,414 shares of the company’s stock worth $2,473,000 after buying an additional 44,630 shares in the last quarter. BXM Wealth LLC purchased a new stake in shares of Fidelity Disruptive Medicine ETF in the fourth quarter worth $243,000. Vise Technologies Inc. bought a new stake in Fidelity Disruptive Medicine ETF during the fourth quarter valued at $234,000. Finally, Virtu Financial LLC bought a new stake in Fidelity Disruptive Medicine ETF during the fourth quarter valued at $228,000.

Fidelity Disruptive Medicine ETF Company Profile

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.